Banking Coalition Pressures Congress on Cannabis Financial Reform
Industry banking group intensifies lobbying efforts as cannabis companies face ongoing financial access barriers despite state-level legalization momentum.
A major banking industry coalition escalates pressure on Congress to advance cannabis banking legislation as financial access barriers continue constraining the $33 billion legal cannabis market. The push comes as cannabis operators across 38 legal states struggle with cash-heavy operations and limited banking relationships that increase operational costs and security risks.
The banking group's renewed advocacy highlights the widening disconnect between state-level cannabis legalization and federal financial regulations. Cannabis companies currently pay effective tax rates exceeding 70% due to IRS Section 280E restrictions while simultaneously facing account closures and payment processing limitations that force many operators into predominantly cash businesses.
Current legislative gridlock on cannabis banking reform creates cascading effects throughout the industry's capital structure. Multi-state operators like Curaleaf Holdings and Green Thumb Industries maintain complex banking relationships across different jurisdictions, while smaller operators often resort to expensive alternative financial services that compress already thin margins in competitive markets.
The banking coalition's timing aligns with growing institutional investor interest in cannabis assets, particularly as several states prepare adult-use market launches in 2026. However, federal banking restrictions continue deterring major institutional capital deployment, limiting industry consolidation opportunities and constraining growth capital access for expansion-focused operators.
Congress faces mounting pressure from both financial institutions seeking regulatory clarity and cannabis companies demanding operational parity with traditional industries. The banking reform debate intersects with broader federal cannabis policy discussions, including DEA rescheduling proceedings and potential comprehensive legalization measures that could reshape the industry's financial landscape within the current legislative cycle.